IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study

Human Genetics

Volumn 122, Issue 5, 2007, Pages 485-494

  Walston, Jeremy D ^a   Fallin, M Daniele ^a   Cushman, Mary ^c   Lange, Leslie ^e   Psaty, Bruce ^b   Jenny, Nancy ^c   Browner, Warren ^d   Tracy, Russell ^c   Durda, Peter ^c   Reiner, Alex ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERIATRIC PATIENT; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AFRICAN AMERICANS; AGED; ALLELES; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; INTRONS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 36348929325     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-007-0428-x     Document Type: Article

References (38)

1. Antonicelli R, Olivieri F, Bonafe M, Cavallone L, Spazzafumo L, Marchegiani F, Cardelli M, Recanatini A, Testarmata P, Boemi M, Parati G, Franceschi C (2005) The interleukin-6-174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 103(3):266-271
2. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE (2001) Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21(9):1458-1463
3. Calabro P, Willerson JT, Yeh ET (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108(16):1930-1932
4. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74(1):106-120
5. Chiappelli M, Tampieri C, Tumini E, Porcellini E, Caldarera CM, Nanni S, Branzi A, Lio D, Caruso M, Hoffmann E, Caruso C, Licastro F (2005) Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 32(6):349-353
6. Cohen HJ, Harris T, Pieper CF (2003) Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 114(3):180-187
7. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41(2):264-270
8. de Maat MP, Bladbjerg EM, Hjelmborg JB, Bathum L, Jespersen J, Christensen K (2004) Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 24(11):2168-2173
9. Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29(2):311-22
10. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245-270
11. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Md JM (2002) Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50(12):1947-1954
12. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369-1376
13. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A (1991) The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1(3):263-276
14. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106(5):506-512
15. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T, Uchida K (2002) Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett 530(1-3):129-132
16. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S (1995) Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5(4):278-285
17. Iwasaki Y, Asai M, Yoshida M, Nigawara T, Kambayashi M, Nakashima N (2004) Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappa B-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 89(7):3449-3454
18. Jenny NS, Tracy RP, Ogg MS, Luong lA, Kuller LH, Arnold AM, Sharrett AR, Humphries SE (2002) In the elderly, interleukin-6 plasma levels and the 174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22(12):2066-2071
19. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O'Leary D, Psaty B, Robbins J (1994) Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in The Cardiovascular Health Study. Am J Epidemiol 139(12):1164-1179
20. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55(1):56-65
21. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis J, Zeng D, Lin D, Kuller L, Nickerson DA, Psaty B, Tracy R, Reiner AP (2006) Polymorphisms in the CRP gene are associated with circulating C-reactive protein levels and cardiovascular events: The Cardiovascular Health Study. JAMA 296(22):2703-2711
22. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49(1):49-67
23. Lin DY (2004) Haplotype-based association analysis in cohort studies of unrelated individuals. Genet Epidemiol 26(4):255-264
24. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem 43(1):52-58
25. Maggio M, Guralnik JM, Longo DL, Ferrucci L (2006) Interleukin-6 in aging and chronic disease: A magnificent pathway. J Gerontol A Biol Sci Med Sci 61(6):575-584
26. Mayosi BM, Avery PJ, Baker M, Gaukrodger N, Imrie H, Green FR, Farrall M, Watkins H, Keavney B (2005) Genotype at the -174G/C polymorphism of the interleukin-6 gene is associated with common carotid artery intimal-medial thickness: Family study and meta-analysis. Stroke 36(10):2215-2219
27. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA (1991) Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 22(9):1155-1163
28. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, D'Onofrio F (1998) Advancing age and insulin resistance: Role of plasma tumor necrosis factor-alpha. Am J Physiol 275(2 Pt 1):E294-E299
29. Pedersen M, Bruunsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E, Dela F, Pedersen BK (2003) Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 124(4):495-502
30. Podgoreanu MV, White WD, Morris RW, Mathew JP, Stafford-Smith M, Welsby IJ, Grocott HP, Milano CA, Newman MF, Schwinn DA (2006) Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 114(Suppl 1):I275-I281
31. Reiner AP, Ziv E, Lind DL, Nievergelt CM, Schork NJ, Cummings SR, Phong A, Burchard EG, Harris TB, Psaty BM, Kwok PY (2005) Population structure, admixture, and aging-related phenotypes in African American adults: The cardiovascular health study. Am J Hum Genet 76(3):463-477
32. Riches P, Gooding R, Millar BC, Rowbottom AW (1992) Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods 153(1-2):125-131
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425-434
34. Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC (2006) Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: Results from the rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 26(1):212-217
35. Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y (2004) Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: Potential relevance to menstruation. J Reprod Dev 50(2):215-225
36. Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275(24):18138-18144
37. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB (2001) Cardiovascular disease, interleukin-6, and risk of mortality in older women: The Women's Health and Aging Study. Circulation 103(7):947-953
38. Zakai NA, Katz R, Jenny N, Psaty B, Reiner AP, Schwartz SM, Cushman M (2007) Inflammation biomarkers and cardiovascular risk in the elderly: The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 5(6):1125-1127